<p>Tom Mitro of Aerie Pharmaceuticals opens up to OIS Podcast host Ehsan Sadri, MD, about the company’s key programs, including the Phase II trial of netarsudil ophthalmic solution for treatment of open-angle glaucoma.</p>

Tom Mitro of Aerie Pharmaceuticals opens up to OIS Podcast host Ehsan Sadri, MD, about the company’s key programs, including the Phase II trial of netarsudil ophthalmic solution for treatment of open-angle glaucoma.

Mitro Opens Up About Aerie’s Programs

<p>Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.</p>

Business

Entrepreneurship

Technology

Investing

Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.

Share Mitro Opens Up About Aerie’s Programs

Sign up to save your podcasts

Mitro Opens Up About Aerie’s Programs

Mitro Opens Up About Aerie’s Programs

More shows like OIS Podcast | Ophthalmology's leading Podcast

Global News Podcast

Ophthalmology off the Grid by Eyetube

How I Built This with Guy Raz

New Retina Radio by Eyetube

White Coat Investor Podcast

The Daily

Up First from NPR

JAMA Ophthalmology Author Interviews

The Indicator from Planet Money

The Journal.

MedEdTalks - Ophthalmology

Experts InSight

ACQ2 by Acquired

Ophthalmology Journal

Eyewire News: The Podcast